Paolo Cavarzere Selected Research

Paolo Cavarzere Research Topics

Disease

3	Congenital Hypothyroidism (Cretinism) 11/2021 - 01/2008
3	Hypertension (High Blood Pressure) 11/2020 - 09/2015
3	Precocious Puberty 03/2020 - 03/2010
2	Overweight 10/2022 - 05/2020
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2022 - 01/2021
2	Hypothyroidism 01/2021 - 08/2014
2	Obesity 01/2021 - 11/2020
2	Fatty Liver 11/2020 - 03/2019
2	Osteogenesis Imperfecta (Lobstein Disease) 06/2020 - 07/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Chronic Disease (Chronic Diseases) 05/2021
1	KBG syndrome 01/2021
1	Cysts 01/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2021
1	Inappropriate ADH Syndrome (SIADH) 01/2021
1	Disease Progression 01/2021
1	Diabetes Insipidus 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Hyponatremia 01/2021
1	Hypocalcemia 06/2020
1	non-verbal learning disabilities 01/2020
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 09/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2019
1	Infertility (Sterility) 01/2019
1	Essential Osteolysis 01/2019
1	Pain (Aches) 01/2019
1	Delayed Puberty 01/2019
1	Gynecomastia 01/2019
1	Chylothorax 01/2019
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2017
1	Neutropenia 07/2017
1	Lysinuric Protein Intolerance 01/2015
1	Thyroid Nodule (Nodule, Thyroid) 08/2014
1	Thyroid Dysgenesis (Thyroid Agenesis) 08/2014
1	Osteonecrosis (Kienbock's Disease) 07/2012
1	Platybasia (Basilar Impression) 09/2010
1	Hypertrophy 12/2008
1	Birth Weight (Birth Weights) 01/2005

Drug/Important Bio-Agent (IBA)

5	Growth Hormone (Somatotropin)IBA 01/2021 - 09/2010
4	Diphosphonates (Bisphosphonates)IBA 06/2020 - 09/2010
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2020 - 03/2010
2	Vitamin D FDA LinkGeneric 10/2022 - 06/2020
2	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 01/2022 - 01/2005
2	Vasopressins (Vasopressin)IBA 01/2021 - 09/2019
2	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 06/2020 - 07/2012
2	Palmitic Acid (Hexadecanoic Acid)IBA 05/2020 - 03/2019
1	ResveratrolIBA 10/2022
1	CurcuminIBA 10/2022
1	MagnesiumIBA 10/2022
1	SeleniumIBA 10/2022
1	ZincIBA 10/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2021
1	TabletsIBA 11/2021
1	SolutionsIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Tolvaptan FDA Link 01/2021
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2021
1	SodiumIBA 01/2021
1	Antidiuretic AgentsIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 11/2020
1	CalciumIBA 06/2020
1	palmitoleic acidIBA 05/2020
1	Triptorelin Pamoate (Trelstar)FDA Link 03/2020
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 03/2020
1	Arginine Vasopressin (Argipressin)IBA 09/2019
1	Triglycerides (Triacylglycerol)IBA 03/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2019
1	InterferonsIBA 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	Transaminases (Aminotransferases)IBA 10/2017
1	DiamondIBA 07/2017
1	MineralocorticoidsIBA 09/2015
1	methylamphotericin B (AME)IBA 09/2015
1	ReninIBA 09/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2015
1	NucleotidesIBA 08/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	Pamidronate (Aredia)FDA LinkGeneric 07/2012
1	NitrogenIBA 07/2012
1	Risedronic Acid (Actonel)FDA LinkGeneric 07/2012
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2012
1	Zoledronic Acid (Zometa)FDA Link 07/2012
1	SteroidsIBA 03/2010
1	inhibin BIBA 12/2008
1	IodidesIBA 01/2008
1	perchlorateIBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
1	Enzyme Replacement Therapy 01/2018
1	Physical Therapy Modalities (Physical Therapy Technique) 09/2010